Jason R. Fangusaro
MD
Dr. Fangusaro has expertise and specialty training in treating children with central nervous system malignancies, including brain and spinal cord tumors.
Titles and Roles
- Professor, Department of Pediatrics
- Emory University School of Medicine
- Director of Developmental Therapeutics
- Aflac Cancer and Blood Disorders Center
- Medical Director of the Clinical Research Office
- Aflac Cancer and Blood Disorders Center
- Pediatric Neuro-Oncologist
- Pediatric Oncology
- Research Program
- Discovery and Developmental Therapeutics
Biography
Jason Fangusaro, MD, is Director of Developmental Therapeutics and Medical Director of the Clinical Research Office at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta. Dr. Fangusaro is also Professor of Pediatrics at the Emory University School of Medicine and the Carter S. Martin Endowed Chair. As a clinical member of the pediatric neuro-oncology team, he specializes in treating children with central nervous system malignancies, including brain and spinal cord tumors.
Dr. Fangusaro is a member of the Children's Oncology Group Brain Tumor Steering Committee, serves as the Vice Chair of the Pediatric Brain Tumor Consortium and partners with the pharmaceutical industry on investigator-initiated trials. He holds professional memberships with American Society of Clinical Oncology, Society for Neuro-Oncology and Children's Oncology Group.
Education
Dr. Fangusaro received his MD from Loyola University Stritch School of Medicine in Chicago, Illinois. He did his residency at Lutheran General Children's Hospital in Chicago, Illinois. He completed a Pediatric Hematology/Oncology Fellowship at Nationwide Children's Hospital in Columbus, Ohio and a Pediatric Neuro-Oncology Fellowship at Children's Hospital of Los Angeles in California.
Research
Dr. Fangusaro's primary area of research is the development of early phase clinical trials, novel therapeutics and relevant biologic correlates in an effort to improve survival outcomes and minimize toxicities. Within pediatric brain tumors, his research has focused on two main areas: low grade gliomas (LGG) and central nervous system (CNS) germ cell tumors (GCTs).
He is a member of both the LGG and CNS GCT international consensus panels, and also serves as the principal investigator and co-investigator on numerous national trials.
Publications
Publications Publication Date